Janaki Emani, MD
Otolaryngology · Lugoff, SCNPI 1841450962
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (56.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Stryker accounts for 60.9% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $2,203 and has fallen 85.4% since, to $321 in 2025.
Across 83 payments — averaging $49.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Medtronic$524
- Optinose US, Inc.$464
- Sanofi$210
- Smith+Nephew$61
- GSK$56
- plus $292 from 11 others
What the payments were for
- Consulting fees$1504%
- Travel & lodging$1,63040%
- Food & beverage$2,32857%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 21 | $2,501 |
| Medtronic(2 entities) | 7 | $524 |
| Optinose US, Inc. | 27 | $464 |
| Sanofi | 7 | $210 |
| Smith+Nephew | 4 | $61 |
| GSK | 3 | $56 |
| Philips North America LLC | 2 | $56 |
| Novartis | 3 | $54 |
| Forte Bio-pharma LLC | 1 | $36 |
| Amgen | 1 | $28 |
| Novo Nordisk | 1 | $21 |
| Pentax Of America, Inc. | 1 | $18 |
| Intersect ENT, Inc. | 1 | $18 |
| Merck | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| Acclarent, Inc | 1 | $14 |
| Phadia US Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$1,874
- FUSION$245
- XPRESS ENT DILATION SYSTEM$171
- CLARIFIX$130
- LATERA$125
How this compares
$4,109 in reported general payments places this provider in the 80th percentile of 180 otolaryngology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 206 | $4,655 |
| Fluticasone Propionate | 231 | $3,053 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 15 | $1,901 |
| Ipratropium Bromide | 62 | $1,860 |
| Montelukast Sodium | 135 | $1,406 |
| Ofloxacin | 30 | $687 |
| Levocetirizine Dihydrochloride | 45 | $570 |
| Omeprazole | 47 | $481 |
| Fluocinolone Acetonide Oil | 14 | $393 |
| Famotidine | 44 | $305 |
| Amoxicillin | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Lugoff
- Jacob OssoffLugoff$5K
- Shaun NguyenCharleston$973K
- Rodney SchlosserCharleston$382K
- Zachary SolerCharleston$67K
- Peter HorwichNorth Charleston$33K
- Eugene BrownCharleston$28K
- Jason NewmanCharleston$26K
- Joshua HornigCharleston$25K
- Ashli OrourkeCharleston$21K
- Alexandra KejnerCharleston$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.